Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

E L Matteson; K N Gold; D A Bloch; G G Hunder

doi:10.1016/s0002-9343(97)89458-2

Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

Am J Med. 1996 Feb;100(2):193-6. doi: 10.1016/s0002-9343(97)89458-2.

Authors

E L Matteson¹, K N Gold, D A Bloch, G G Hunder

Affiliation

¹ Division of Rheumatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.

PMID: 8629654
DOI: 10.1016/s0002-9343(97)89458-2

Abstract

Objective: To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort.

Patients and methods: Follow-up was obtained for 205 (95.8%) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population.

Results: There were 49 deaths (33 women and 16 men among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 +/- 0.121), and was similar for women (SMR = 1.022 +/- 0.149) and men (SMR = 1.078 +/- 0.206) (SMR = 1 indicates that expected and observed survival are identical).

Conclusion: The life expectancy of patients with giant cell arteritis is the same as that of the general population.

Publication types

Multicenter Study
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Female
Giant Cell Arteritis / mortality*
Humans
Male
Middle Aged
Prognosis
Survival Analysis
Survival Rate

Abstract

Publication types

MeSH terms

Grants and funding